Neumora Therapeutics Inc (NMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Operating Expenses | 263,464 | 252,098 | 135,870 |
| Operating Income | -263,464 | -252,098 | -135,870 |
| Other Income | 19,855 | 16,441 | 4,966 |
| Pre-tax Income | -243,609 | -235,657 | -130,904 |
| Income Tax | 178 | 268 | N/A |
| Net Income Continuous | -243,787 | -235,925 | -130,904 |
| Net Income | $-243,787 | $-235,925 | $-130,904 |
| EPS Basic Total Ops | -1.53 | -3.63 | -4.81 |
| EPS Basic Continuous Ops | -1.53 | -3.63 | -4.81 |
| EPS Diluted Total Ops | -1.53 | -3.63 | -4.81 |
| EPS Diluted Continuous Ops | -1.53 | -3.63 | -4.81 |
| EPS Diluted Before Non-Recurring Items | -1.53 | -3.63 | -4.81 |
| EBITDA(a) | $-268,552 | $-255,171 | $-135,984 |